• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

25/11/2025 20:06

Bliss GVS Pharma - General Updates

Bliss GVS Pharma Limited has informed the Exchange that Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Bliss GVS International PTE Ltd , Singapore, a wholly owned subsidiary of Bliss GVS Pharma Limited ( the Company ), has incorporated a wholly owned subsidiary namely Theralife Pharma Ltd , Nairobi, Kenya.